Cargando…
PTEN Status Assessment in the Johns Hopkins Active Surveillance Cohort
BACKGROUND: Up to half of men with Gleason score 6 (GS6) prostate cancers initially managed with active surveillance (AS) will eventually require definitive therapy, usually due to tumor grade reclassification during follow-up. We examined the association between PTEN status on biopsy and subsequent...
Autores principales: | Tosoian, Jeffrey J., Guedes, Liana B., Morais, Carlos L., Mamawala, Mufaddal, Ross, Ashley E., De Marzo, Angelo M., Trock, Bruce J., Han, Misop, Carter, H. Ballentine, Lotan, Tamara L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372343/ https://www.ncbi.nlm.nih.gov/pubmed/30279579 http://dx.doi.org/10.1038/s41391-018-0093-2 |
Ejemplares similares
-
PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for Active Surveillance
por: Trock, Bruce J., et al.
Publicado: (2016) -
Longitudinal Assessment of Urinary PCA3 for Predicting Prostate Cancer Grade Reclassification in Favorable Risk Men during Active Surveillance
por: Tosoian, Jeffrey J., et al.
Publicado: (2017) -
Johns Hopkins Hospital
Publicado: (1914) -
The Johns Hopkins Hospital Reports
por: Struthers, J. W.
Publicado: (1904) -
The Johns Hopkins Hospital Reports
Publicado: (1894)